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Abstract 
SH residues on the rabbit intestinal brush-border membrane Na+/phosphate cotransporter were examined using a variety of SH 
specific reagents, proteolytic digestion and HPLC separation of SH-labeled cotransporter, and partial reaction assays. Of the seven 
SH-containing peptide fragments on the non-denatured non-reduced cotransporter six peptides were labeled: five SH-containing peptides 
were labeled with acrylodan or IAF (iodoacetamidofluorescein) and three peptides were labeled with IAEDANS. One SH-containing 
peptide was labeled with IAEDANS or fluorescein maleimide only. Selective SH labeling conditions employing acrylodan and IAEDANS 
were used to identify the environments of these SH-containing peptides in the native cotransporter. The nature of SH reagent-induced 
inhibition of Na+-dependent phosphate uptake was examined using substrate-induced conformational changes, and substrate-induced 
changes in IAEDANS and acrylodan fluorescence of the SH-labeled Na+/phosphate cotransporter. The results indicate that five of the 
SH-labeled peptides ense the Na+-induced conformational change, three peptides ense the Na++ difluorophosphate-induced conforma- 
tional change, and one peptide senses only the Na++ monofluorophosphate-induced conformational change. Five of the SH-labeled 
peptides are passive participants in the substrate-induced conformational changes with only SH 51 involved in cotransporter function. 
Alkylation of SH 51 resulted in a cotransporter conformation which differed from the substrate-mediated conformations and was 
characterized by increased monofluorophosphate sensitivity. 
Keywords: Sodium ion/phosphate cotransporter; Phosphate transport; Inhibition; Sulfhydryl specific reagent; Molecular mechanism; Brush-border 
membrane; (intestine) 
I. Introduction 
Sulfhydryl residues are thought o be involved in sub- 
strate transport in a variety of membrane transport proteins 
including the intestinal [1-3] and renal [4,5] brush-border 
membrane Na +/phosphate cotransporters. The role of these 
residues in substrate transport is poorly understood. Chem- 
ical modification studies examining the role of SH residues 
in membrane transport have been limited by multiple SH 
residues per transport protein, the non-competitive nature 
of the sulfhydryl reagent-induced inhibition, transport pro- 
tein specific and non-specific SH reagent effects, the ab- 
sence of partial reaction assays to define SH involvement 
in the transport cycle, and the absence of corroborating 
effects in site-directed mutagenesis tudies. Considering 
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the significant role of SH residues in carrier-mediated 
substrate transport across biological membranes and pro- 
tein structure [6-8] understanding the mechanism of SH 
chemical modification-induced inhibition of membrane 
transport proteins is an important area of research. 
An initial step in understanding the molecular mecha- 
nism of SH reagent chemical modification and inhibition 
of substrate transport is the development of methods of 
identifying the number of labeled residues, defining the 
environments of the residues in the native protein and 
examining the effect of SH residues on the transport 
protein using partial reaction assays. We have developed 
partial reaction assays which identified four conformations 
of the Na+/phosphate cotransporter which are consistent 
with these conformations being involved in substrate trans- 
port [9]. Using these conformational assays the macro- 
molecular mechanism of SH reagent-induced inhibition of 
Na+/phosphate cotransport was suggested to result from a 
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distinct but altered Na + conformation [9]. These results 
contrast with similar studies of the Na+/glucose cotrans- 
porter which suggested an altered substrate-free conforma- 
tion [10,11]. 
We have extended the examination of the role of SH 
residues in substrate transport using the environment-sensi- 
tive SH reagents, acrylodan and IAEDANS, to examine 
the SH-containing peptides of the intestinal brush-border 
membrane Na÷/phosphate cotransporter. We have exam- 
ined the effect of SH reagents on substrate-induced confor- 
mational changes, and characterized the direct effects of 
substrates on the SH reagent modified cotransporter. Our 
results suggest that inhibitory SH reagents alter the 
Na+/phosphate cotransporter Na + conformation without 
inhibiting the Na+-induced conformational change. This 
modified Na ÷ conformation resulted in a modified Na++ 
phosphate conformation which had a reduced Vma x. The 
results are consistent with all but one of the SH-containing 
peptides being affected by the Na+-induced conforma- 
tional change as passive participants (fluorescence af- 
fected, but SH-labeling having no effect on Na ÷ or Na++ 
phosphate conformation). Modification of the SH 51 pep- 
tide altered the Na ÷ and Na++ phosphate conformation 
directly. The results also suggest hat with respect o SH 
reagent modified proteins and perhaps other non-competi- 
tive inhibitor-modified proteins, structure/conformation 
relationships might be a more appropriate paradigm than 
structure/function relationships. 
2. Materials and methods 
2.1. Materials 
Chromatofocusing chromatography supplies and 
Sepharose S-200 were purchased from Pharmacia, Piscat- 
away, NJ. [32p]Phosphate was purchased from NEN/Du 
Pont, Boston, MA. Fluorescent SH reagents were pur- 
chased from Molecular Probes, Eugene, OR. Proteolytic 
enzymes, PCMB, PCMBS, iodoacetamide, DTT, NEM, 
phosphatidylcholine, cholesterol, and buffers were pur- 
chased from Sigma, St. Louis, MO. Electrophoretic sup- 
plies were purchased from Bio-Rad, Richmond, CA. TFA 
was purchased from Pierce, St. Louis, MO. All organic 
solvents were purchased from Aldrich, Milwaukee, WI and 
were HPLC grade or better. All other chemicals were 
purchased from Fisher, Plano, TX and were reagent grade 
or better. 
2.2. Methods 
Intestinal brush-border membrane vesicle preparation 
Rabbit intestinal brush-border membrane vesicles were 
prepared by Ca 2÷ precipitation (Ca2+-BBMV) as previ- 
ously described [12]. Ca2+-BBMV protein was resus- 
pended in 300 mM mannitol and 10 mM Hepes-Tris (pH 
7.5), and stored at liquid N 2 temperatures until needed. 
SDS-BBMV protein (SDS-treated Ca 2 ÷-BBMV protein) 
was prepared as previously described [ 13,14]. SDS-BBMV 
protein was resuspended in 300 mM mannitol and 10 mM 
Hepes-Tris (pH 7.5), and stored at liquid N 2 temperatures 
until needed. 
Ca2+-BBMV protein and SDS-BBMV protein purifica- 
tion were assayed using the brush-border nzyme markers, 
alkaline phosphatase [15] and sucrase [16]. Compared to 
the intestinal homogenate activities, Ca2+-BBMV protein 
was 24-fold to 32-fold enriched in alkaline phosphatase 
and sucrase. SDS-BBMV protein was 85-fold to 100-fold 
enriched in these brush-border membrane markers. 
Na+/phosphate cotransporter purification and proteo- 
liposome reconstitution 
The intestinal Na+/phosphate cotransporter was puri- 
fied as previously described [3]. Protein was resuspended 
in 150 mM KCI and 10 mM Hepes-Tris (pH 7.5) at a final 
concentration of 5 mg/ml to 10 mg/ml and stored at 
liquid N 2 temperatures until needed. 
Na+/phosphate cotransporter was reconstituted into 
phosphatidylcholine/cholesterol liposomes as previously 
described [3]. Cotransporter purification was determined 
using a rapid mixing/rapid quenching assay using Na +- 
dependent [32p]phosphate uptake into proteoliposomes 
[3,17]. Na + dependent uptake was determined measured as 
uptake in the presence of 100 mM cis Na ÷ minus uptake 
in the presence of 100 mM cis TMA ÷. 
SH reagent conditions 
50 /xg of proteoliposome r constituted protein were 
reacted with the indicated SH reagent (SH reagent concen- 
tration varied from 10 /zM to 250 ~M) in 100 mM 
TMACI, 50 mM KCI, and 25 mM Hepes-Tris (pH 7.5) 
(SH reaction media) for 2 min at 23°C. The reaction was 
terminated by addition of a 25-fold dilution of ice-cold 100 
mM TMAC1, 50 mM KC1, and 25 mM Hepes-Tris (pH 
7.5). Protein was collected by centrifugation at100 000 × g 
for 60 min. Pellets were resuspended in the appropriate 
media by 10 passes through a 0.23 gauge needle. 
In some experiments proteoliposome r constituted pro- 
tein reacted with PCMB or PCMBS was treated with 50 
mM DTT, and SH reaction media for 20 min at 4°C to 
reverse PCMB and PCMBS binding. The reaction was 
stopped and protein collected by centrifugation as de- 
scribed above. 
Uniform fluorescent SH reagent modification of the 
intestinal brush-border membrane Na+/phosphate cotrans- 
porter by acrylodan, IAEDANS, or IAF, was performed 
with the detergent solubilized cotransporter in 50 mM 
Tris-HCl (pH 7), and 0.1% NOG (n-octyl glucoside) using 
15 ~M fluorescent label in the dark for 15 min at 23°C. 
The reaction was terminated by addition of a 10-fold 
excess of 50 mM Tris-HC1 (pH 7) and 0.1% NOG. The 
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Table 1 
SH reagent  label ing o f  papain f ragments  
Reagent  F ragment  # 
18 23 31 38 43 51 
IAF  X X X X X 
IAF  + PCMBS X X - - 
IAF  + PCMB X - X X - 
Acry lodan X X X X X 
Acry lodan + PCMBS X X - - 
Acry lodan + PCMB X - X X - 
IAEDANS X X X 
IAEDANS + PCMBS X - X 
IAEDANS + PCMB - X X 
NEM + IAEDANS - - - 
X indicates labeled with f luorescent der ivat ive,  no mark  indicates did not 
react, and - indicates protected f rom label ing. 
reactants were washed and concentrated by centrifugation 
(1500 × g for 30 min) through a 1 kDa cut-off ilter using 
an Amicon micropartition system [3,18], followed by dial- 
ysis for 24 h against 10 mM Tris-HCl (pH 7) with three 
buffer changes. 
Specific SH labeling of the detergent solubilized 
Na+/phosphate cotransporter was performed in SH reac- 
tion media + 0.1% NOG according to the protocols in 
Tables 1 and 2. NEM, PCMB, PCMBS, or iodoacetamide 
pretreatment was performed for 10 min at 23°C. The 
reaction was terminated by dilution and protein separated 
from unreacted SH reagent by 1 kDa partition centrifuga- 
tion and dialysis as described above. Removal of PCMB 
and PCMBS with DTT was performed as described above. 
Labeling of the pretreated Na+/phosphate cotransporter 
with fluorescent SH reagents was performed as described 
for uniform SH labeling. 
Experiments examining the role of SH-labeled peptides 
in Na+/phosphate cotransporter function using DTT re- 
versal of PCMB and PCMBS labeling were checked for 
completeness of organic mercurial removal as follows. 
Following fluorescent SH reagent labeling of the cotrans- 
porter and DTT treatment, an aliquot of cotransporter was 
labeled with IAF or Fmal (fluorescein maleimide) as de- 
scribed above. Cotransporter was subsequently digested 
with papain as described below and the SH-labeled pep- 
tides examined by HPLC using the Protein Pak 125 col- 
umn as described below. The effectiveness of DTT rever- 
sal of organic mercurial binding to the cotransporter was 
determined by comparison to direct IAF or Final labeling 
of the cotransporter per milligram fluorescent peptide. 
DTT treatment resulted in greater than 90% removal of 
organic mercurial. 
DTNB labeling of the Na+/phosphate cotransporter 
was performed following protein solubilization i  100 mM 
Tris-HCl (pH 8), 10 mM EDTA, and 0.1% NOG (non-re- 
ducing conditions) or following protein solubilization i  10 
mM Tris-HC1 (pH 8), 1% SDS, 50 mM /3-mercaptoethanol 
and heating at 95°C for 3 min. DTNB determinations were 
performed using 1.5 mg of protein, 500 /zM DTNB, and 
50 mM phosphate buffer (pH 7). The change in absorbance 
at 412 nm was determined as a function of time using a 
Gilford 260 spectrophotometer corrected for DTNB reduc- 
tion (protein blank) and protein absorbance (DTNB blank) 
[19]. 
Proteolytic digestion 
200 /xg of cotransporter o SH reagent treated cotrans- 
porter was resuspended in 100 mM NH4HCO 3 (pH 8), 
0.1% SDS, and 15 mM /3-mercaptoethanol and heated for 
3 min at 95°C. Protein was digested at 1:100, or 1:25 
proteinase/protein ratio (w/w) for varying times (1 h to 6 
h) at 37°C. The reaction was stopped by addition of a 
20-fold excess of soybean trypsin inhibitor (trypsin), TPCK 
(chymotrypsin), iodoacetamide (papain), or difluoroiso- 
propyl phosphate (V-8 proteinase). Protein and peptides 
were concentrated by lyophilization, and dialyzed against 
10 mM Tris-HCl (pH 7) using 1 kDa cut-off dialysis 
tubing. 
Table 2 
SH label ing procedures 
React ion condit ions SH 18 SH 23 SH 31 SH 38 SH 43 SH 51 
1. NEM + PCMB X - X 
2. DTT  
3. IAEDANS X 
4. IAEDANS + PCMB + PCMBS - - X 
1. NEM + PCMBS - X X 
2. DTT  
3. IAEDANS X 
1. NEM X X X 
2. Acry lodan ÷ PCMB X - - 
1. Iodoacetamide  + PCMBS X - X X X 
2. DTT  
3. Acry lodan + PCMB X - 
1. NEM X X X 
2. lodoacetamide  + PCMB X - - 
3. DTT  
4. Acry lodan + PCMBS X 
1. NEM + PCMB X - X 
2. Iodoacetamide  + PCMB X X - 
3. DTT  
4. Acry lodan + PCMBS X - 
1. NEM X X X 
2. Iodoacetamide  + PCMBS X X - 
3. DTT  
4. Acry lodan X 
X indicates labeled with f luorescent der ivat ive,  no mark  indicates did not 
react, and - indicates protected f rom labeling. 
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Peptide fragments resolved by HPLC (Protein Pak 125 
fractions and RP C 4 column fractions) were dialyzed 
against 10 mM Tris-HCl (pH 7) using 1 kDa cut-off 
dialysis tubing to reduce SDS concentration. Following 
dialysis, peptides were concentrated by lyophilization and 
resuspended in the appropriate media. 
CNBr hydrolysis 
HPLC fractions or Na+/phosphate cotransporter were 
resuspended in 70% formic acid and treated with an equal 
amount (w/w)  of CNBr in 70% formic acid for 18 hours 
in the dark under N 2. The reaction was terminated by a 
20-fold dilution with 10 mM Tris-HC1 (pH 7), and the 
mixture lyophilized. This step was repeated twice to ensure 
complete removal of CNBr. 
HPLC purification of peptides 
Peptide fragments were initially resolved on a 7.8 mm 
X 30 cm Waters Protein Pak 125 column with 50 mM 
Tris-HCl (pH 7), and 0.1% SDS at a flow rate of 0.4 
ml/min. Protein was monitored at 215 nm using a Waters 
Lambda Max 481 variable wavelength UV/Vis  detector. 
Fluorescence was monitored using a Kratos Spectroflow 
980 fluorescence detector. Fluorescence was excited at 290 
nm and monitored using band pass filters (fluorescein, 
above 500 nm; acrylodan, above 450 nm; and IAEDANS, 
above 400 nm). 
SH-labeled peptide fragments were collected, dialyzed, 
and resuspended in 0.1% TFA. Peptide fragments were 
resolved on a Waters C 4 column using a 60 min linear 
gradient of 0.1% TFA and 0.1% TFA + 70% CH3CN at a 
flow rate of 0.5 ml/min. 
Secondary peptide fragments were generated from the 
primary (V-8 proteinase or papain) SH-labeled fragments 
following two C 4 column purifications. Peptide fragments 
were resuspended in 100 mM NH4HCO 3 (pH 8), 0.1% 
SDS, and 15 mM /3-mercaptoethanol and digested with 
chymotrypsin (V-8 proteinase primary peptide fragments) 
or V-8 proteinase (primary papain fragments) for 4 h at 
37°C at a peptide/proteinase ratio of 25:1. Peptides were 
lyophilized and dialyzed as described above. Secondary 
peptide fragments were resolved on the C a column using a 
linear gradient of 0.1% TFA and 0.1% TFA/70% CH3CN 
as described above. SH 23 and SH 18 peptides were 
further resolved on a Waters RP CN column using a 60 
min linear gradient of 20% l-propanol and 80% 1-pro- 
panol at a flow rate of 0.4 ml/min. 
Fluorescence spectroscopy 
All fluorescence xperiments were performed on an 
SLM SPF 500 C spectrofluorometer at 23°C set in the ratio 
mode. Acrylodan fluorescence was excited at 390 nm and 
emission recorded as a function of wavelength from 400 
nm to 600 nm. IAEDANS fluorescence was excited at 337 
nm and recorded as a function of wavelength from 350 nm 
to 600 nm. 
The effect of substrates on acrylodan and IAEDANS 
fluorescence was performed in 500 mM KCI, 0.1% NOG, 
and 50 mM Tris-HC1 (pH 7). The fluorescence was 
recorded and NaCI was then added to a final concentration 
of 100 mM from a 3 M stock and the fluorescence 
recorded. Monofluorophosphate (final concentration 25 
/xM) or difluorophosphate (final concentration 200 /zM) 
were then added and the fluorescence r corded. The results 
are presented as change in fluorescence, AF/F  (change in 
fluorescence/initial fluorescence). 
Experiments examining the Na+-induced conforma- 
tional change using FITC-PG fluorescence quenching were 
performed as previously described [17,20]. 50 /zg of pro- 
tein was labeled with FITC-PG in 50 mM Tris-HC1 (pH 7) 
and 0.1% NOG as previously described [17,20]. FITC-PG 
fluorescence quenching was examined using 10 p~g of 
protein, 0.1% NOG, 0.5 M KCI, and 50 mM Tris-HC1 (pH 
7). Where indicated 100 mM KCI or 100 mM NaC1 were 
added from 3 M stock solutions. 
Inner filter effects were minimized by maintaining pro- 
tein concentrations below 0.02 O.D. units. Light scatter 
was corrected using deproteinated proteoliposomes a  pre- 
viously described [21,22]. Dilution artefacts were corrected 
by comparison of the effects of NaCI and KC1 on fluores- 
cence emission and minimized by using concentrated stock 
solutions. 
Tryptophan fluorescence 
Tryptophan fluorescence xperiments were performed 
on an SLM SPF 500 C at 23°C set in the ratio mode. 
Tryptophan fluorescence was examined using 15 p~g of 
protein, in 0.5 M KCI, 0.1% NOG (n-octyl glucoside), and 
50 mM Tris-HC1 (pH 7). The excitation wavelength was 
set at 290 nm and emission at 350 nm recorded. In some 
experiments emission was recorded as a function of wave- 
length from 300 nm to 400 nm. Excitation and emission 
slit widths were 2.5 nm. 
The effect of substrates on tryptophan fluorescence 
were examined by addition from concentrated stocks to 
minimize dilution artefacts. Results were analyzed using a 
non-linear egression fit of the fluorescence r sults. Exper- 
iments examining the effect of phosphate, fluorophos- 
phates, or arsenate were performed in the presence of 150 
mM NaCl. 
SDS-PAGE electrophoresis 
Polyacrylamide gel electrophoresis was performed ac- 
cording to the method of Laemmli [23] using 7.5% slab 
gels, or 10% to 22% linear gradient gels. In experiments 
using linear gradient gels fluorescein sulfonate was substi- 
tuted for Bromophenol blue as the tracking dye. Fluores- 
cein sulfonate runs with the ion front, allowing resolution 
of small (< 3 kDa) peptides. 
In some experiments gel lanes were excised and ana- 
lyzed by scanning densitometry using a Gilford spectro- 
photometer with the gel scanner. IAF or Fmal absorbance 
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was monitored at 470 rim, and Coomassie blue absorbance 
was monitored at 550 rim. 
Protein assays 
SDS-BBMV protein and Ca2+-BBMV protein were as- 
sayed by the method of Bradford using bovine IgG as 
standard [24]. All chromatography fractions and proteo- 
liposome reconstituted protein were assayed using the 
SDS-micro Lowry assay with BSA as standard [25]. 
Chemical synthesis 
FITC-PG was synthesized as previously described [20]. 
FITC-PG was purified using a Sepharose-polylysine col- 
umn, eluted with 50 mM potassium tetraborate buffer (pH 
7.4), and a silica gel column developed with butanol/acetic 
acid/water (50:40:10, v /v )  as previously described [20]. 
Potassium monofluorophosphate nd potassium difluo- 
rophosphate were prepared as previously described [14,26]. 
3. Results 
3.1. SH reagent labeling of  the Na+/phosphate cotrans- 
porter 
Na+-dependent phosphate uptake by the intestinal 
Na+/phosphate cotransporter has been reported to be sen- 
Lane  # 1 2 Molecular Mass 
kDa kDa 
97 .5  
66 .2  
43.5  
31 .5  
21 .4  
14 .4  
200 
116.25  
97 .5  
66 .2  
8.5  
o 
T .  D.  
5 
A 
Fig. 1. SDS-PAGE of primary papain and primary V-8 proteinase digestion ofNa+/phosphate cotransporter. (A) 100 /zg of Na+/phosphate cotransporter 
was digested with papain (lane 1) or V-8 proteinase (lane 2) at a protein/proteinase ratio of 100:1 (w/w) for 4 h at 37°C in 100 mM NH4HCO 3 (pH 8) 
and 0.1% SDS. The reaction was quenched asdescribed in Methods. 25 /zg was resolved on a 10-22% linear gradient gel. Results are from a single 
experiment and representative of five separate experiments. (B) 25 /zg of Na+/phosphate cotransporter was run on a 7.5% SDS-PAGE gel and stained 
with Coomassie blue as described inMethods. Results are from a single cotransporter preparation a d representative of four preparations. 
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sitive to the SH reagents, iodoacetamide and organic mer- 
curials (PCMB and PCMBS) but not to NEM [3]. To 
examine this difference in SH reagent sensitivity we exam- 
ined SH labeling of the cotransporter. DTNB labeling of 
the Na+/phosphate cotransporter was consistent with 13 
SH residues (12.6 _+ 0.6, n = 3) on the reduced, denatured 
Na+/phosphate cotransporter, and seven SH residues (6.6 
-I-0.3, n = 3) on the non-reduced, non-denatured 
Na+/phosphate cotransporter being accessible to DTNB 
labeling. SH labeling by iodoacetamide and NEM of the 
intestinal brush-border membrane Na+/phosphate cotrans- 
porter was examined using proteolytic digestion of labeled 
cotransporter. The results are summarized in Figs. 1-3. 
Fig. 1A is a Coomassie blue stained 10% to 22% linear 
gradient SDS-PAGE gel of the peptide fragments gener- 
ated by proteolytic digestion of the Na+/phosphate co- 
transporter with papain (lane 1) or V-8 proteinase (lane 2). 
Multiple peptide fragments were generated by both pro- 
teinases ranging from 60 kDa to 6 kDa. For comparison, 
the undigested Na+/phosphate cotransporter is shown in 
Fig. 1B. 
The Na+/phosphate cotransporter labeled with IAF 
(iodoacetamidofluorescein) was also digested with papain 
(Fig. 2 top), V-8 proteinase (Fig. 2 middle), or chemically 
hydrolyzed with CNBr (Fig. 2 bottom). IAF-labeled pep- 
tides (broken lines) were determined by fluorescein ab- 
sorbance prior to Coomassie blue staining (solid line). The 
results are consistent with five IAF-labeled peptides on the 
non-denatured, non-reduced Na+/phosphate cotransporter. 
Similar experiments with IAEDANS-Iabeled cotransporter 
resulted in three peptides being labeled with this SH 
reagent, one of which appeared to be unique to IAEDANS 
(results not shown). 
3.2. HPLC resolution Na +/phosphate cotransporter frag- 
ments 
Polypeptides resulting from papain or V-8 proteinase 
proteolytic digestion of the IAF-labeled, acrylodan-labeled, 
and IAEDANS-labeled Na+/phosphate cotransporter were 
also examined by HPLC using an initial separation by the 
Protein Pak 125 column followed by C 4 column purifica- 
tion of the SH-labeled peptides using a linear gradient of 
0.1% TFA and 0.1% TFA/70% CH3CN. The peptide 
fragments containing SH-labeled residues were subse- 
quently digested with chymotrypsin (V-8 proteinase I ° 
fragments), or V-8 proteinase (papain digestion I° frag- 
ments) and then separated on the C 4 column. Four pep- 
tides, SH 18 and SH 23 from the papain/V-8 proteinase 
digestion protocol, and SH 19 and SH 21 from the V-8 
proteinase/chymotrypsin digestion protocol were hydro- 
iyzed with CNBr (SH 18, and SH 23) and resolved on a 
RP CN column, or pepsin digested (SH 19 and SH 21) and 
resolved on the C 4 column to ensure that these peptides 
were not incomplete digestion products of each other. The 
results of these studies are summarized in Fig. 3. 
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Fig. 2. SDS-PAGE resolution of CNBr, papain, and V-8 proteinase 
pepetide fragments. 125 /zg of Na+/phosphate cotransporter was uni- 
formly labeled with IAF as described in Methods. Labeled cotransporter 
was hydrolyzed with CNBr for 12 h at 23°C (top), digested with papain 
(middle), or V-8 proteinase (bottom) was resolved on a 10% to 22% 
linear gradient gel, examined for IAF fluorescence (broken line) and then 
stained with Coomassie blue (solid line). Results are representative for 
three separate xperiments• 
Using the papain/V-8 proteinase digestion protocol and 
HPLC analysis, labeling methods pecific for IAF-labeled 
peptides and IAEDANS-labeled peptides were developed. 
Identical labeling patterns were seen with IAF labeling and 
acrylodan labeling. The specific SH-containing peptides 
labeling methods are summarized in Methods. 
3.3. Specific SH labeling 
Acrylodan labeling of the Na+/phosphate cotransporter 
resulted in two broad fluorescence emission peaks (results 
not shown). A peak centered near 470 nm corresponding to 
acrylodan-labeled residues in hydrophobic environments 
(fluorescence emission of acrylodan in acetonitrile is at 
B.E. Peerce et al. / Biochimica et Biophysica A cta 1239 (1995) 11-21 17 
SH Res idue  (Protein Pak 125) 
Protease/ SH 18 SH 23 SH 31 SH 38 SH 43* SH 51 
(elution 
time, min.) 
V-8 8 7 
C 4 1 3 
(elution 22 35 
time, min.) 
v-8/Chymotrypsin 
s.121 SRi4 s. i, s.i  
e 4 
chymotrypsin ~ L 
Pepsin 
C 4 F- 
@ 21 
Sn 19"  
I 
28 45 
12 
Fig. 3. Primary and secondary digestion fragments of the Na +/phosphate 
cotransporter. IAF- or IAEDANS-Iabeled cotransporter was digested with 
papain or V-8 proteinase as described in Methods. Peptide fragments 
were resolved on a Waters Protein Pak 125 HPLC column as described in 
Methods. Fluorescent peptide fragments were further resolved on a 
Waters RP C 4 HPLC column, and subjected to secondary digestion 
(papain fragments with V-8 proteinase, and V-8 proteinase fragments 
with chymotrypsin). Peptide fragments were resolved on the C 4 column. 
Numbers represent column elution time and circled fragments represent 
fluorescent fragments. Results summarize a total of 35 HPLC experi- 
ments. * IAEDANS labeled. ~ following 45-min linear gradient of 70% 
CH3CN, a 30-rain linear gradient of 70% CH3CN / 20% THF was run. 
This fragment eluted at 10% THF. 
450 nm), and a second peak centered at 515 nm corre- 
sponding to acrylodan in a hydrophilic environment 
(acrylodan emission in water is at 530 nm). 
Acrylodan emission of SH residues labeled at specific 
residues of the Na+/phosphate cotransporter based on 
proteolytic polypeptide fragment analysis is shown in Fig. 
4. Three general emission regions were seen. SH 18 (open 
dots) and SH 23 (solid dots) had fluorescence mission 
maxima near 460 nm and were classified as being located 
in hydrophobic sectors of the Na+/phosphate cotrans- 
porter. SH 51 (solid line) and SH 31 (dashed line) had 
emission maxima near 530 nm and were classified as 
being located in hydrophilic regions of the cotransporter. 
Intermediate between these two extremes, SH 38 had an 
emission maxima near 510 nm. 
The fluorescence mission of IAEDANS-Iabeled pep- 
tides (SH 23, SH 38, and SH 43) are shown in Fig. 5. In 
agreement with our analysis of acrylodan-labeled peptides, 
IAEDANS-labeled SH 23 bad a fluorescent emission con- 
sistent with a bydropbobic environment (IAEDANS emis- 
sion at 360 nm) and IAEDANS-labeled SH 38 had an 
hydrophilic emission (470 rim). Labeling of SH 43 was 
unique to IAEDANS. SH 43 appeared to reside in an 
environment more hydrophobic than SH 38, but more 
hydrophilic than SH 23 (IAEDANS emission at 380 nm). 
3.4. SH polypeptide fragments involL'ed in Na+-dependent 
phosphate uptake 
The selective SH labeling procedures summarized in the 
Methods were used to identify the SH residue(s) involved 
in non-competitive inhibition of Na+-dependent phosphate 
uptake. Three assays of cotransporter function were used 
to examine cotransporter function: (1) Na+-induced FITC- 
PG fluorescence quenching, (2) substrate-induced trypto- 
phan fluorescence quenching, and (3) Na+-dependent 
phosphate uptake. The results are summarized in Figs. 
6-8. 
Fig. 6 shows the effect of NEM or iodoacetamide 
labeling of the SH-containing peptides on Na+-dependent 
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Fig. 4. Acrylodan fluorescence mission of Na+/phosphate cotrans- 
porter. 50-/zg aliquots of cotransporter were labeled with acrylodan at the 
specified SH residue(s) as described in Table 1. Acrylodan fluorescence 
was determined using 15 p.g of labeled cotransporter in 500 mM KC1, 20 
mM Tris-HC1 (pH 7), and 0.1% NOG. Acrylodan fluorescence was 
excited at 390 nm and emission recorded between 400 nm and 600 nm. 
Results are from a single experiment and representative of five experi- 
ments. Solid line, SH 51; solid dots, SH 23; dashed line, SH 31; and open 
dots. SH 18. 
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Fig. 5. IAEDANS fluorescence mission of Na+/phosphate cotrans- 
porter. 50 /.tg of Na+/phosphate cotransporter was labeled with 
IAEDANS at the specified SH residue(s) as described in Table 1. 
IAEDANS fluorescence was determined using 15 /xg of labeled protein 
in 500 mM KCI, 20 mM Tris-HCI (pH 7), and 0,1% NOG. IAEDANS 
fluorescence was excited at 337 nm and the emission recorded from 350 
nm to 500 nm. Results are from a single experiment and representative of 
four experiments. Solid line, SH 23; dashed-dotted line, SH 38; dashed 
line, SH 43. 
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Fig. 6. Effect of labeling of SH-containing peptides on Na+-dependent 
phosphate uptake. 75/.tg of proteoliposome reconstituted Na ÷/phosphate 
cotransporter was labeled with iodoacetamide or NEM at the indicated 
SH residue(s) as described in Tables 1 and 2. Na+-dependent phosphate 
uptake was determined as described in Methods. Results are means + S.E. 
of triplicate determinations and are representative of four experiments. 
phosphate uptake. Na÷-dependent phosphate uptake was 
inhibited by iodoacetamide labeling of SH peptide 51. 
Labeling of SH 18, 23, 31, 38 or 43 (NEM) had no effect 
on Na+-dependent phosphate uptake. 
SH labeling of SH-containing peptides 18, 23, 31, 38, 
or 43 had no effect on the Na+-induced conformational 
change measured by Na+-induced FITC-PG fluorescence 
quenching (results not shown) or Na+-induced tryptophan 
fluorescence quenching (Fig. 7, open bars). Iodoacetamide 
labeling of SH 51 resulted in a slight decrease in the 
magnitude of the Na+-induced conformational change (33 
+3%, n=4) .  
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Fig. 7. Effect of substrates on tryptophan fluorescence of iodoacetamide- 
and NEM-labeled cotransporter. 75 /.~g of Na+/phosphate cotransporter 
was labeled with iodoacetamide or NEM at the indicated SH residue(s) as 
described in Methods. Tryptophan fluorescence was determined using 15 
txg of protein, 500 mM KCI, 20 mM Tris-HC1 (pH 7), and 0.1% NOG. 
Tryptophan fluorescence was excited at 290 nm and emission at 350 nm 
recorded. The change in fluorescence was determined following addition 
of 100 mM NaCI and recorded as (F K - FNa)/F K (open bars), following 
addition of 200 /.LM potassium difluorophosphate nd recorded as (FNa -- 
FNa+DFP)/FNa (hatched bars), or Na + +50 /~M potassium onofluo- 
rophosphate and recorded as (FN, -- FNa + MFP)/FN, (solid bars). Results 
are means___ S.E. of triplicate determinations and five experiments. 
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Fig. 8. Effect of substrates on acrylodan-and IAEDANS-labeled 
Na +/phosphate cotransporter. Na +/phosphate cotransporter was labeled 
with acrylodan or IAEDANS as described in Methods. Acrylodan and 
IAEDANS fluorescence was determined as described in Methods. Effect 
of substrates on acrylodan or IAEDANS fluorescence was determined as 
described in the legend to Fig. 7. Open bars, 100 mM NaCI; hatched bars, 
100 mM NaCl+200 /xM potassium difluorophosphate; and solid bars, 
Na + + 50 p,M potassium onofluorophosphate. Results are means _+ S.E. 
of triplicate determinations and four experiments. 
The apparent K05 values for Na + were unaffected by 
SH labeling of the SH-containing peptides by iodoacet- 
amide (parent compound of IAF), NEM (parent compound 
of IAEDANS), or PCMB (results not shown). These re- 
sults are consistent non-competitive inhibition of Na+-de - 
pendent phosphate uptake by SH reagents [3,4]. 
Fig. 7 (hatched bars) shows that the tryptophan fluores- 
cence quenching upon addition of phosphate (difluo- 
rophosphate) in the presence of Na ÷ (Na++ phosphate- 
induced conformational change) was inhibited by iodoacet- 
amide or organic mercurial labeling of SH 51. Iodoacet- 
amide or NEM labeling of the other SH residue containing 
peptides had no effect on the Na++ phosphate-induced 
conformational change. Similar results were seen with 
Na++ monofluorophosphate (Fig. 7, solid bars). Labeling 
SH 51 resulted in a fluorescence enhancement of trypto- 
phan fluorescence not seen in untreated controls nor fol- 
lowing SH labeling of the other SH-containing peptides. 
Acrylodan and IAEDANS fluorescence has been shown 
to be environment sensitive [27,28]. The effect of sub- 
strates on acrylodan and IAEDANS fluorescence bound to 
the Na+/phosphate cotransporter at specific SH-contain- 
ing peptides was examined to determine the role of the 
SH-containing peptides in substrate-induced conforrna- 
tional changes. The results are summarized in Fig. 8. 
The fluorescence of five SH-containing peptides was 
affected by the addition of Na + (Fig. 8, open bars). The 
response to Na + was SH-containing peptide dependent 
varying from 20% (SH 23) to 12% (SH 51). Only SH 43 
did not respond to Na +. SH 18 and SH 23 responded to 
Na++ difluorophosphate (Fig. 8, hatched bars). Addition 
of Na + and difluorophosphate resulted in a 13% quench- 
ing of SH 18 fluorescence and a 9% quenching of SH 23 
acrylodan fluorescence. SH 51 and SH 38 did not respond 
to Na++ difluorophosphate. SH 43 did not respond to 
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Na + or Na++ difluorophosphate. Only SH 43 had a sig- 
nificant response to Na++ monofluorophosphate (12% flu- 
orescence nhancement). 
3.5. Effect of labeling SH 51 on Na +/phosphate cotrans- 
porter conformation 
The inhibition of Na+-dependent phosphate uptake (Fig. 
6), and the inhibition of tryptopban fluorescence quenching 
(Fig. 7) following iodoacetamide labeling of SH 51 are 
consistent with this SH-containing peptide being involved 
in Na+-dependent phosphate uptake. The effect of labeling 
SH 51 with iodoacetamide, on the remaining SH residues 
and tryptophan fluorescence quenching in response to sub- 
strates is shown in Fig. 9. 
Labeling of SH 51 with iodoacetamide inhibited the 
Na ++ difluorophosphate-induced onformational change 
and resulted in a tryptophan fluorescence nhancement in 
the presence of Na++ monofluorophosphate. Identical ef- 
fects were seen following labeling of the other SH-contain- 
ing peptides (Fig. 9). 
Fig. l0 compares the effect of iodoacetamide labeling 
of peptide 51 on the substrate-induced quenching of the 
other acrylodan- and IAEDANS-Iabeled peptides. As pre- 
viously reported [9] SH labeling did not alter SH-labeled 
peptide quenching by Na +. The response to Na++ 
phosphate was altered. SH 18 and SH 23 retained SH 
reagent fluorescence quenching in the presence of Na + 
and difluorophosphate similar to the quenching seen prior 
to SH 5t labeling. SH 18 quenching was 30% reduced, 
and SH 23 quenching was 35% to 45% reduced following 
SH 51 labeling. SH 38 which had little fluorescence 
quenching in the presence of Na++ difluorophosphate, and 
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Fig. 9. Effect of substrates on tryptophan fluorescence of the Na+/phos - 
phate cotransporter labeled at SH 51 with iodoacetamide. Na+/phos - 
phate cotransporter was labeled with iodoacetamide at SH 51 as described 
in Methods. Cotransporter was then labeled with either iodoacetamide or 
NEM at the indicated SH residue(s) as described in Methods. Tryptophan 
fluorescence and the effect of substrates on tryptophan fluorescence was 
determined as described in Methods and the legend to Fig. 7. Open bars, 
Na+; hatched bars, Na + +difluorophosphate; and solid bars. Na++ 
monofluorophosphate. R sults are means_+S.E, of triplicate determina- 
tions and four experiments. 
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Fig. t0. Effect of substrates on acrylodan and IAEDANS fluorescence of
SH 51 labeled Na+/phosphate cotransporter. Na+/phosphate cotrans- 
porter was labeled with iodoacetamide at SH 51 as described in Methods. 
Labeled cotransporter was then labeled with acrylodan or IAEDANS at 
the indicated SH residue(s). Effect of substrates on acrylodan or 
IAEDANS fluorescence was determined as described in Methods. Open 
bar, Na+; hatched bar, Na + +difluorophosphate; and solid bar, Na++ 
monofluorophosphate. R sults are means_+ S.E. of triplicate determina- 
tions and five experiments. 
SH 43 which did not respond to Na ÷ or difluorophosphate 
had similar responses to substrates following SH 51 label- 
ing. SH 31 did not respond to Na++ difluorophosphate 
following labeling of SH 51. The major affect of SH 51 
labeling appeared to be the response to Na + + 
monofluorophosphate. Prior to labeling SH 51, only 
IAEDANS bound to SH 43 had a fluorescence nhance- 
ment in the presence of Na++ monofluorophosphate. Fol- 
lowing labeling of SH 51, SH 23 and SH 38 responded to 
Na++ monofluorophosphate. These results are consistent 
with the major effect of non-competitive inhibitory SH 
reagents being an altered Na ÷ conformation resulting in 
altered fully loaded conformations. 
4. D iscuss ion 
The generation of a model of the molecular mechanism 
of non-competitive inhibition of membrane transport was a 
major goal of our studies. The first step in the development 
of this model was to determine the number of SH residues 
accessible to SH reagents on the native Na+/phosphate 
cotransporter and to determine identifying characteristics 
which could be used to assay selective labeling procedures. 
The second step was to use transport cycle partial reactions 
to better define the reaction(s) sensitive to SH reagents. 
Four identifying SH characteristics were found. The 
first characteristic was peptide digestion. Of the seven SH 
residues labeled with DTNB, six of these peptides were 
identified by papain or V-8 proteinase digestion, or CNBr 
hydrolysis. The second characteristic was differential SH 
reagent labeling. Three SH-containing peptides were la- 
beled with NEM and its derivatives. Five SH-containing 
peptides were labeled with acrylodan, iodoacetamide, and 
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iodoacetamide derivatives. The third characteristic was 
differential SH reagent sensitivity. NEM and its derivatives 
had no effect on Na+/phosphate cotransporter function. 
Iodoacetamide, acrylodan, IAF, and organic mercurials 
inhibited cotransporter function. The fourth characteristic 
was SH environment as determined by fluorescence emis- 
sion of acrylodan-labeled and IAEDANS-labeled peptides. 
SH 18 and SH 23 were identified as being located in 
hydrophobic environments. SH 38, SH 31 and SH 51 were 
identified as being located in hydrophilic environments, 
and SH 43 was identified as being located in intermedi- 
ate/hydrophobic environment. 
Analysis of the role of SH-containing peptides in co- 
transporter function involved comparison of the effect of 
labeling on Na+-dependent phosphate uptake and sub- 
strate-induced conformational changes to the effect of 
substrates on SH-labeled fluorescence. In this analysis, a 
SH-containing peptide which did not alter cotransporter 
function, and did not respond (fluorescence quenching or 
enhancement) substrates was considered not to be involved 
in cotransporter function. SH-containing peptides which 
did not alter cotransporter function, but whose fluores- 
cence was substrate sensitive were considered to partici- 
pate indirectly and not have an active role in cotransporter 
function. SH-containing peptides whose labeling altered 
cotransporter function and whose fluorescence was sub- 
strate sensitive were thought o be active participants in 
cotransporter function. Using these criteria, SH 18, 23, 31, 
38, and 51 'sense' the Na+-induced conformational change, 
and SH 51 has an active role in this conformational 
change. SH 18, 23, and 31 'sense' the Na++ 
difluorophosphate-induced conformational change, and SH 
51 has an active role in this conformational change. SH 43 
has no role in substrate transport, but does 'sense' the 
inhibitory Na++ monofluorophosphate-induced conforma- 
tional change. 
Labeling SH-containing peptide SH 51 resulted in a 
slight (33%) inhibition of Na+-induced tryptophan fluores- 
cence quenching, and a 83% inhibition of the Na++ 
difluorophosphate-induced conformational change. These 
results are consistent with previous tudies suggesting that 
SH reagent inhibition of Na+-dependent phosphate uptake 
was the result of an altered Na + conformation resulting in 
an altered Na++ difluorophosphate conformation [9]. The 
results in Figs. 9 and 10 indicate that one result of 
SH-containing peptide SH 51 labeling was to alter the 
cotransporter response to monofluorophosphate. 
Monofluorophosphate is thought o bind to an intercel- 
lular/intervesicular site on the cotransporter resulting in 
inhibition of Na+-dependent phosphate uptake. Monofluo- 
rophosphate competes with difluorophosphate for two con- 
formations, but apparently does not compete for difluo- 
rophosphate (substrate) binding site [9]. The alternative is
also true. Difluorophosphate does not compete with 
monofluorophosphate for its binding site [29]. The obser- 
vation that SH 51 alkylation results in a Na++ 
monofluorophosphate sensitive conformation is likely a 
manifestation of SH 51 labeling. From the stand point of 
the molecular mechanism of SH reagent inhibition of 
cotransporter function, this monofluorophosphate respon- 
siveness could result in increased sensitivity to intercellu- 
lar divalent phosphate, increased cotransporter cycling time, 
or increased competition between the Na + + 
difluorophosphate conformation (transport competent) and 
the Na++ monofluorophosphate conformation (transport 
inhibited). 
Our results also suggest that of the accessible SH 
residues only those on SH 51 are involved in substrate-in- 
duced conformational changes and substrate transport. 
Alkylation of SH residue(s) on peptide SH 51 resulted in a 
conformational change. Therefore, while removal of 
these/this SH residues/residue might alter the cotrans- 
porter conformation, it seems unlikely that it would result 
in the conformation described here. The cotransporter con- 
formation was altered such that the response to substrates 
by multiple SH-containing peptides was altered. That this 
conformation did not conform to a typical substrate loaded 
conformation, for example the Na + conformation [9] makes 
it unlikely that a single residue was responsible for the 
gross changes in cotransporter behavior eported here. 
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